about
sameAs
Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humansHow common are the "common" neurologic disorders?Genome-wide association study reveals genetic risk underlying Parkinson's diseasealpha-Synuclein locus triplication causes Parkinson's diseaseThe BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohortLewy bodies and parkinsonism in families with parkin mutationsComparison of kindreds with parkinsonism and alpha-synuclein genomic multiplicationsStroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes.Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of dataKnowledge gaps and research recommendations for essential tremor.Agreement between TOAST and CCS ischemic stroke classification: the NINDS SiGN study.Whole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery.Amyotrophic lateral sclerosis: an emerging era of collaborative gene discoveryUsing previously genotyped controls in genome-wide association studies (GWAS): application to the Stroke Genetics Network (SiGN)Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling studyProfile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family.A clinical and pathological study of motor neurone disease on Guam.The genetics of disorders with synuclein pathology and parkinsonism.CoAIMs: a cost-effective panel of ancestry informative markers for determining continental origins.Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group.Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria.Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens.SCA2 may present as levodopa-responsive parkinsonism.Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease.Exercise-induced dystonia as a preceding symptom of familial Parkinson's disease.Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease.The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases.Pain in Parkinson's disease. Common yet seldom recognized symptom is treatable.Genome-wide analysis of the parkinsonism-dementia complex of Guam.Development and characterization of simple sequence repeats for Bipolaris sorokiniana and cross transferability to related species.Genetics of parkinsonism.Familial Lewy body diseases.Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α-synuclein triplication (Iowa kindred).Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus.Prevalence of Parkinson's disease in populations of African ancestry: a review.Genetic testing in Parkinson's disease.The role of radiotracer imaging in Parkinson disease.
P50
Q21092490-1E0E0A75-0DDB-44BA-9A06-F9EC6D9DE87AQ22306182-954D230F-2F92-4DED-98F8-2EF09DD7B48EQ24646654-65B277BF-56EE-4ADC-A294-AE49D013163AQ27860533-EE490DEC-B6DB-4D5C-90BB-16D29EA1253EQ28076121-57CFE0B5-8C91-4D6B-BA8F-BC52008FE4B6Q28216308-217F7B56-5F52-4FA9-A771-A9CF2FD3230BQ28241852-4991BC34-C92C-417A-9157-BA873924E8F1Q28658238-FE21E841-C4C8-432F-BE3D-BD3E80E32C80Q28943545-E60F59F5-38D6-4469-B857-A7D5053326A5Q30244228-934D1338-996F-475D-B885-5F23B1784910Q30405640-7E91AE68-DCFF-4125-83A1-276C605FED12Q30440018-C54093F4-C9A7-48A9-ABC5-231264C98D22Q30444138-E42E8007-812B-46FF-8498-4EAACF33CE6EQ30458056-3DEB069A-B4F1-4FAF-A402-3B7E36E99EE7Q30485675-8CEC81A5-81C4-41CD-9996-06D447E898FEQ30664901-2262471C-A1FE-4EC6-A50B-53B9CA66E0C4Q30938617-89D6D82B-945B-40E0-990A-4B6749E3C894Q31932101-65819DAF-208F-43E3-B9FE-617C97E4B855Q33183044-627F2B23-7AD2-4A9E-AA92-F3600D4D5919Q33724101-2E79E7E6-B33B-48C8-B810-F9C6770C951EQ33728463-A6A34457-647D-4C58-A2CB-B2D357C67B2CQ33736409-449B8D2D-58BD-4A2E-9BA0-D8BFE082A6A1Q33858726-6FD19C48-FC9D-4223-9641-40E7D9AC1D25Q33984113-6D62BCC2-6201-4E95-A98A-87210270E46BQ33988883-A8D35155-9693-4D81-B5B8-EDAC14DEAC02Q34187852-2FD51D52-307A-4C0B-B5B6-43D3A1BEB22DQ34294160-322DD710-0B93-4F4C-8B58-CD1E02E45D32Q34300379-A0B3F32B-015B-41F6-98CE-A799169D2F09Q34376115-5CA93B14-3F12-4DA9-AC4E-2F8B7040A91EQ34443373-F59A940D-0D67-4DDF-B8AE-7498930BB9DBQ34490424-1AB2CDEF-77AC-48FD-B6B6-F8C2F3DE483CQ34553381-8C1139A3-08CD-4431-9BD6-44DADBBC751FQ34741309-397670AC-87A6-4986-B0EC-E03A8E5AFEE4Q34811944-367445BF-1B1B-4B5E-917F-D1A657A1277DQ35029476-75320C7D-4137-4886-B9CC-2A8A861B1463Q35207288-9BCED718-5D69-46FB-A1D9-80402927020CQ35692589-F7ED9723-F2C0-475F-8A82-6B957C2B403AQ35836224-3530598C-608F-49CB-9529-EE5741BD8460Q35927013-3A9F6F30-8BFB-484F-BA9E-17DE3DB6863DQ36019158-A134CBEA-FB48-4E3A-885D-5D1F1DBA95D3
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Katrina Gwinn
@en
Katrina Gwinn
@es
Katrina Gwinn
@nl
Katrina Gwinn
@sl
Katrina Gwinn-Hardy
@fr
type
label
Katrina Gwinn
@en
Katrina Gwinn
@es
Katrina Gwinn
@nl
Katrina Gwinn
@sl
Katrina Gwinn-Hardy
@fr
altLabel
Gwinn K
@en
Gwinn K.
@en
Gwinn
@en
Gwinn-Hardy K
@en
Gwinn-Hardy K.
@en
Gwinn-Hardy
@en
K Gwinn
@en
K Gwinn-Hardy
@en
K. Gwinn
@en
K. Gwinn-Hardy
@en
prefLabel
Katrina Gwinn
@en
Katrina Gwinn
@es
Katrina Gwinn
@nl
Katrina Gwinn
@sl
Katrina Gwinn-Hardy
@fr
P108
P106
P108
P21
P2798
P31
P4012
P496
0000-0002-8277-651X